Kerendia (finerenone) is a medication prescribed to treat chronic kidney disease (CKD) associated with type 2 diabetes [1]. Currently, there are no direct generic substitutes for Kerendia [2].
What is Finerenone and How Does it Work?
Finerenone, the active ingredient in Kerendia, is a non-steroidal selective mineralocorticoid receptor antagonist [1]. It works by reducing the harmful effects of excess mineralocorticoid receptor stimulation in the kidneys and heart, which can be associated with CKD and type 2 diabetes [1][3]. This mechanism helps to slow the progression of kidney damage [1].
When Does the Patent for Kerendia Expire?
The patents protecting Kerendia are complex and vary by region. DrugPatentWatch.com tracks patent expiries for medications, including Kerendia [2]. While specific patent expiry dates are proprietary and can be subject to legal challenges, general patent protection typically lasts for a number of years after a drug's approval [4]. Information on Kerendia's patent status can be found on sites like DrugPatentWatch.com [2].
Are There Alternative Treatments for CKD in Type 2 Diabetes?
While Kerendia is a distinct therapeutic option, other treatments aim to manage CKD in patients with type 2 diabetes. These may include:
* Blood Sugar Control: Maintaining tight control of blood glucose levels through diet, exercise, and oral antidiabetic medications or insulin is fundamental [5].
* Blood Pressure Management: Medications such as ACE inhibitors and ARBs are commonly used to lower blood pressure and protect the kidneys [5].
* SGLT2 Inhibitors: Drugs like dapagliflozin and empagliflozin have also shown significant benefits in reducing the risk of CKD progression and cardiovascular events in this patient population [6].
* Lifestyle Modifications: Dietary changes, such as reducing sodium intake and protein consumption, along with regular physical activity, are also important components of management [5].
Can Generic Versions of Kerendia Be Developed?
Generic versions of a drug can only be developed and marketed after the relevant patents expire and regulatory approval is obtained. Given that Kerendia is a relatively newer medication, generic development would depend on the timelines of its patent protections [4].
What is the Cost of Kerendia?
The cost of Kerendia can vary depending on insurance coverage, pharmacy, and dosage. Patients often explore patient assistance programs or inquire about potential cost savings through their healthcare provider or pharmacist [7].
Sources:
[1] https://www.kerendia.com/
[2] https://drugpatentwatch.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326991/
[4] https://www.fda.gov/drugs/patent-certification/understanding-drug-patents
[5] https://www.niddk.nih.gov/health-information/kidney-disease/type-2-diabetes
[6] https://www.nejm.org/doi/full/10.1056/NEJMoa2002387
[7] https://www.kerendia.com/savings-and-support